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Sir2 is an NAD-dependent deacetylase that
connects metabolism with longevity in yeast,
flies, and worms. Mammals have seven Sir2
homologs (SIRT1–7). We show that SIRT4 is a
mitochondrial enzyme that uses NAD to ADP-
ribosylate and downregulate glutamate dehy-
drogenase (GDH) activity. GDH is known to
promote the metabolism of glutamate and glu-
tamine, generating ATP,which promotes insulin
secretion. Loss of SIRT4 in insulinoma cells ac-
tivates GDH, thereby upregulating amino acid-
stimulated insulin secretion. A similar effect is
observed in pancreatic b cells from mice defi-
cient inSIRT4oron thedietary regimenof calorie
restriction (CR). Furthermore, GDH from SIRT4-
deficient or CRmice is insensitive to phosphodi-
esterase, an enzyme that cleaves ADP-ribose,
suggesting the absence of ADP-ribosylation.
These results indicate that SIRT4 functions in
b cell mitochondria to repress the activity of
GDHbyADP-ribosylation, therebydownregulat-
ing insulin secretion in response to amino acids,
effects that are alleviated during CR.
INTRODUCTION
Silent information regulator (Sir2) genes promote longev-
ity in yeast, C. elegans, and Drosophila (for review, seeBlander and Guarente, 2004). An extra copy of the yeast
SIR2 gene extends replicative life span of mother cells
compared to wild-type, while a deletion of SIR2 reduces
life span (Kaeberlein et al., 1999). Sir2 proteins are NAD-
dependent deacetylases, and the yeast Sir2p silences se-
lected regions of the yeast genome (Imai et al., 2000;
Landry et al., 2000). Silencing by Sir2p suppresses the for-
mation of extrachromosomal rDNA circles, which trigger
senescence in mother cells (Kaeberlein et al., 1999; Sin-
clair and Guarente, 1997). In C. elegans, the SIR2 ortholog
sir-2.1 regulates life span by at least two mechanisms. In
one, it augments the activity of the forkhead protein
DAF-16, a longevity determinant in worms (Berdichevsky
et al., 2006). In the other, it regulates the transcription of
genes involved in the unfolded-protein stress response
(Viswanathan et al., 2005). In yeast and Drosophila, SIR2
and its paralogs are required for the life-span extension
brought on by calorie restriction (CR) (Lamming et al.,
2005; Lin et al., 2000; Rogina and Helfand, 2004; Wood
et al., 2004), raising the question of whether mammalian
SIR2 genes connect nutrient sensing to life span.
Mammals have seven Sir2p homologs (sirtuins, SIRT1–
7) (Frye, 2000). While a role for mammalian sirtuins in
life-span regulation has not been directly determined, ev-
idence suggests that the ortholog SIRT1 plays roles in
numerous physiological pathways, such as control of glu-
cose homeostasis. Pancreatic b cells maintain glucose
homeostasis by secreting insulin in response to an in-
crease in ATP due to the metabolism of glucose. SIRT1
deacetylates the forkhead transcription factor FOXO1
(Brunet et al., 2004; Luo et al., 2001; Motta et al., 2004;
Vaziri et al., 2001) and thereby promotes resistance toCell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc. 941
oxidative stress in b cells (Kitamura et al., 2005). SIRT1
also functions as a positive regulator of insulin secretion
in b cells by repressing expression of the mitochondrial
uncoupling protein UCP-2 (Moynihan et al., 2005; Bor-
done et al., 2005). In the liver, SIRT1 interacts with and
deacetylates PGC-1a to induce gluconeogenesis in re-
sponse to fasting (Rodgers et al., 2005).
Functions for the other SIR2 genes, SIRT2–7, in mam-
malian physiology have only recently begun to emerge.
SIRT6 is an ADP-ribosyltransferase (Liszt et al., 2005)
and plays an important role in base excision repair of nu-
clear DNA (Mostoslavsky et al., 2006). SIRT6 knockout
mice show defects in proliferative tissues and a premature
aging phenotype (Mostoslavsky et al., 2006). SIRT7 is
located in the nucleolus, where, analogous to the yeast
Sir2p, it regulates transcription by RNA polymerase I
(Ford et al., 2006). However, unlike Sir2p, which silences
rDNA by deacetylating histones (Armstrong et al., 2002),
SIRT7 appears to bind directly to the RNA pol I complex
and exert a positive effect on transcription.
In this paper, we provide the first comprehensive char-
acterization of SIRT4, which was proposed to be a mito-
chondrial protein because SIRT4-GFP localizes to that
cellular compartment (Michishita et al., 2005). We show
that, unlike SIRT1–3 (North et al., 2003), SIRT4 does not
display NAD-dependent deacetylase activity but instead
uses NAD to ADP-ribosylate glutamate dehydrogenase
(GDH), an enzyme that converts glutamate to a-ketogluta-
rate in mitochondria. By ADP-ribosylating GDH, SIRT4
represses the enzymatic activity of GDH and limits the
metabolism of glutamate and glutamine to generate ATP.
Therefore, SIRT4 represses the ability of b cells to secrete
insulin in response to these amino acids, and, as pre-
dicted, SIRT4 knockout mice secrete insulin in response
to glutamine. In wild-type mice, CR alleviates the repres-
sion of GDH by ADP-ribosylation and thus changes the
response of b cells to glutamine and leucine. These find-
ings demonstrate the role of a mammalian sirtuin in regu-
lating an important physiological pathway that responds
to CR.
RESULTS
SIRT4 Is Expressed in Mouse Pancreatic b Cells
To identify tissues in which SIRT4 may have a physiologi-
cally relevant function, we first investigated the expression
pattern of SIRT4 in mouse. SIRT4 was expressed in all tis-
sues examined, with highest levels in the kidney, heart,
brain, and liver (Figure 1A). Despite its apparent low level
in the pancreas (Figure 1A), an intense SIRT4 signal was
detected specifically within pancreatic islets, overlapping
the expression of insulin in b cells (Figure 1B, see also
close-up in Figure S1A in the Supplemental Data available
with this article online), suggesting a possible role in the
regulation of insulin secretion (see below). By contrast,
SIRT4 showed a diffuse localization pattern in mouse kid-
ney and liver (data not shown).942 Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc.SIRT4 Is a Mitochondrial ADP-Ribosyltransferase
Mammalian homologs of SIR2 are localized to the nucleus
(Liszt et al., 2005; Luo et al., 2001; Vaziri et al., 2001), cy-
tosol (North et al., 2003), and mitochondria (Onyango
et al., 2002; Schwer et al., 2002). To determine SIRT4
subcellular localization, we fused GFP to the C terminus
of human SIRT4 (SIRT4-GFP). Human liver HepG2 cells
expressing phSIRT4GFP displayed colocalization of
SIRT4-GFP with a mitochondria-targeted DsRed, but not
peroxisome-targeted DsRed (Figure 1C). By contrast,
GFP alone showed a diffuse localization pattern. These
data are in agreement with a recent report that overex-
pressed SIRT4-GFP is localized to the mitochondria of
human fibroblasts (Michishita et al., 2005).
We verified the mitochondrial localization of endoge-
nous SIRT4 in the mouse insulinoma b cell line MIN6 by
subcellular fractionation using a polyclonal antibody gen-
erated against the C terminus. SIRT4 was enriched in mi-
tochondrial fractions containing the mitochondrial protein
HSP60 (Figure 1D) but not detectable in the cytosolic frac-
tion containing catalase. Endogenous and overexpressed
SIRT4 was also detected in the mitochondrial fraction of
human 293T cells (data not shown). These results demon-
strate that SIRT4 is localized to the mitochondria of human
and mouse cells.
We next investigated whether SIRT4 is posttranslation-
ally cleaved during mitochondrial import by sequencing
the N terminus of SIRT4-FLAG. The N terminus of many
mitochondrial proteins becomes cleaved by signal pepti-
dases during import to the matrix. The first 28 predicted
amino acid residues were absent from the N terminus, in-
dicating that SIRT4 had been posttranslationally pro-
cessed (Figure 1E). Like the putative signal sequence of
another mitochondrial sirtuin, SIRT3 (Schwer et al.,
2002), that of SIRT4 is enriched in basic residues (Fig-
ure 1E). Taken together, our data show that SIRT4 is a mi-
tochondrial protein, is posttranslationally cleaved, and
likely resides in the mitochondrial matrix.
While SIRT1–3 have been shown to be NAD-dependent
deacetylases, the activity of SIRT4 has not been estab-
lished. To investigate the enzymatic activity of SIRT4, we
overproduced human SIRT4 with a C-terminal FLAG tag
in mammalian cells. 293T cells expressing SIRT4-FLAG
produced a 34 kDa band that was immunoreactive to
both FLAG and SIRT4 antibodies (Figure 2A). We as-
sessed the enzymatic activity of SIRT4-FLAG immunopre-
cipitated from mammalian cells. Although SIRT4 contains
a conserved sirtuin domain (Frye, 2000), we detected no
deacetylase activity, in contrast to the known deacetylase
SIRT1 (Figure 2B). Instead, we found that SIRT4 trans-
ferred a radiolabel indicative of an ADP-ribosyl group
from NAD onto histones (Figure 2C), and this transfer
was inhibited by 1 mM nicotinamide, which is known to in-
hibit the activity of sirtuins (Figure 2C). By contrast, SIRT5
did not show ADP-ribosyltransferase activity. Mass spec-
trometry analysis confirmed that SIRT4 transferred a
540 dalton moiety to histone 2A, corresponding to the
molecular weight of ADP-ribose (Figure S1B). These data
Figure 1. SIRT4 Is a Mitochondrial Protein Expressed in Pancreatic b Cells
(A) Tissue lysates (20 mg) from two mice were combined and analyzed by SDS-PAGE and Western blotting using SIRT4, GDH, and GAPDH antibodies.
(B) Sections of mouse pancreas were analyzed by immunofluorescence using antibodies to SIRT4 (red) and insulin (green). Nuclei were visualized with
DAPI (blue, 103 magnification).
(C) HepG2 cells were cotransfected with phSIRT4-EGFP (green), the mitochondrial marker pDs-RED2-Mito (red), or the peroxisomal marker pDs-
RED-Peroxi (red).
(D) MIN6 cells were fractionated by sucrose centrifugation. Cell = whole-cell lysate, N = nuclear lysate/unbroken cells, S = light fraction containing
cytosol, mito = enriched mitochondria. Blot was probed with antibodies to cytosolic catalase, mitochondrial HSP60, or SIRT4.
(E) N-terminal presequence hSIRT4 as deduced by comparing the N-terminal sequence from protein isolated from mammalian cells to the cDNA se-
quence. Also shown is the hSIRT3 presequence (Schwer et al., 2002).show that SIRT4 is an ADP-ribosyltransferase but do
not completely rule out a substrate-specific deacetylase
activity.
SIRT4 Interacts with GDH
To characterize the in vivo role of SIRT4 as a mitochondrial
ADP-ribosyltransferase, we sought to identify proteins
that were relevant physiological substrates of this sirtuin.
Previous studies suggest that a small number of mito-
chondrial proteins may be ADP-ribosylated (Jorcke
et al., 1998). The best characterized is GDH, a mitochon-
drial enzyme that converts glutamate into the TCA-cycle
intermediate a-ketoglutarate and is inhibited by ADP-ribo-
sylation (Herrero-Yraola et al., 2001). We therefore inves-
tigated whether GDH was a bona fide substrate for
ADP-ribosylation by SIRT4 within mitochondria.To probe a functional interaction between these pro-
teins, we first analyzed the expression profile of GDH in
mouse tissues. GDH was expressed ubiquitously
(Figure 1A) and, like SIRT4, was highly enriched in pancre-
atic islets localizing to b cells (Figure 2D). We also de-
tected GDH expression in a ring of cells surrounding the
insulin-containing cells.
We next investigated whether SIRT4 and GDH physi-
cally interact in 293T cells expressing SIRT4-FLAG. Immu-
noprecipitating SIRT4-FLAG coprecipitated endogenous
GDH in cells expressing the tagged construct (Figure 2E).
Conversely, immunoprecipitating endogenousGDHpulled
down SIRT4-FLAG in these same cells (Figure 2E).
Control antibodies against Gal4 did not immunoprecipitate
GDH or SIRT4-FLAG. Moreover, we detected GDH in
SIRT4 immunoprecipitates from MIN6 cells (Figure 2F),Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc. 943
Figure 2. SIRT4 Is a NAD-Dependent ADP-Ribosyltransferase that Interacts with GDH
(A) 293T cells were transiently transfected with pCMV-FLAG vector (control) or phSIRT4-FLAG, and protein expression was verified by Western blot-
ting with FLAG or hSIRT4 antibodies normalized to actin.
(B) Fifty nanograms of immunoprecipitated, dialyzed hSIRT4-FLAG (T4) and hSIRT1-FLAG (T1) were assayed for deacetylase activity using the Fluor
de Lys substrate (BIOMOL) in the absence (open bars) or presence (black bars) of 1 mM NAD.
(C) ADP-ribosyltransferase activity of hSIRT4-FLAG (T4), hSIRT5-FLAG (T5), and buffer control (C) was determined by incubating 50 ng of protein with
[32P]NAD in the presence of core histone proteins without or with 1 mM nicotinamide.
(D) Sections of mouse pancreas were probed with antibodies to GDH (red) and insulin (green); nuclei were visualized with DAPI (blue, 103 magnifi-
cation).
(E) 293T cells were transfected with pCMV vector (C) or phSIRT4-FLAG (4), and lysates were immunoprecipitated with Gal4, FLAG, or GDH antibodies
and subjected to Western blot using antibodies against FLAG or GDH.
(F) MIN6 cells lysates were immunoprecipitated with Gal4 or SIRT4 antibodies and blotted with antibodies for GDH or SIRT4.demonstrating that SIRT4 and GDH interact at endoge-
nous levels found in pancreatic b cells.
SIRT4 ADP-Ribosylates and Inhibits GDH
To determine whether SIRT4 could ADP-ribosylate GDH,
we incubated SIRT4 immunoprecipitated from isolated
mammalian mitochondria with purified GDH for varying
times. We monitored ADP-ribosylation of GDH by the
transfer of radiolabel from [32P]NAD to GDH. SIRT4 cata-
lyzed the transfer of radiolabel, which was removed by
treatment with phosphodiesterase (PDE), an enzyme
known to cleave ADP-ribose (Figure 3A) (Cervantes-Lau-
rean et al., 1993; Schwab et al., 2000). ADP-ribosyltrans-944 Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Incferase activity was inhibited by two structurally distinct in-
hibitors of sirtuins, nicotinamide and sirtinol (Grozinger
et al., 2001) (Figure 3B), further indicating that ADP-ribosy-
lation of GDH was catalyzed by SIRT4.
We next measured the enzymatic activity of recombi-
nant hSIRT4 expressed and purified from Pichia pastoris.
Like hSIRT4-FLAG, recombinant hSIRT4 exhibited ADP-ri-
bosyltransferaseactivityon GDH(Figure3C), and thisactiv-
ity was inhibited by nicotinamide (Figure S1C). In contrast,
recombinant SIRT1 purified from bacteria did not ADP-
ribosylate GDH to the same extent as SIRT4 (Figure S1C).
Mono-ADP-ribosylated proteins can be generated by
two mechanisms: direct enzymatic transfer of ADP-ribose.
Figure 3. SIRT4 ADP-Ribosylates and Inhibits GDH
(A) ADP-ribosylation of GDH by hSIRT4-FLAG was assessed by incu-
bating 10 mg of GDH with [32P]NAD in the presence (lanes a–c) or
absence (lanes d–f) of 10 ng SIRT4 for the indicated times, and the
30 min sample was then treated without (lane g) or with (lane h) phos-
phodiesterase (PDE; 10 mg/ml). Samples were analyzed by autoradi-
ography, and GDH in each lane from the same gel was detected by
Ponceau S.
(B) ADP-ribosylation of GDH by hSIRT4-FLAG was assessed as in (A)
without (NIC) or with nicotinamide (+NIC, 10 mM) or with 40 mM sirti-
nol for 5, 30, or 60 min at 37C.
(C) ADP-ribosylation of GDH by recombinant hSIRT4 was assessed by
incubating 10 mg of GDH with 0.1 mg of hSIRT4 or control buffer for the
indicated times.
(D) Thin-layer chromatography (TLC) was used to analyze [32P]NAD
(lane 1) and metabolites generated when [32P]NAD was incubatedfrom NAD, and noncatalytically by reacting with free ADP-
ribose (Jorcke et al., 1998). To explore which mechanism
might apply, we tested whether SIRT4 cleaved NAD to
generate free ADP-ribose, which could then label GDH
nonenzymatically. Thin-layer chromatography (TLC) was
used to analyze the NAD metabolites generated when
SIRT4 was incubated with NAD in the absence or pres-
ence of GDH (Figure 3D). Lane 2 shows the production
of free ADP-ribose when NAD was incubated with NAD
glycohydrolase, which cleaves NAD to yield ADP-ribose
and nicotinamide. As another control, incubation of the
bacterial sirtuin Sir2Tm with an acetylated p53 peptide,
JB12, produced O-acetyl-ADP-ribose (lane 6), a known
product of the deacetylation reaction. In contrast, reac-
tions containing recombinant hSIRT4 and NAD without
(lane 4) or with GDH (lane 5) did not produce free ADP-ri-
bose, nor did incubation of NAD with GDH (lane 3). These
results suggest that SIRT4 does not function as an NAD
glycohydrolase to cleave NAD. Instead, SIRT4 likely
ADP-ribosylates GDH by direct transfer of ADP-ribose
from NAD.
As ADP-ribosylation is known to inhibit GDH activity
(Herrero-Yraola et al., 2001), we determined whether
SIRT4 inhibited GDH by incubating SIRT4-FLAG (or
SIRT1-FLAG) with bovine GDH in the presence of
NAD. Blotting with anti-FLAG approximated the levels of
these sirtuins used in the reactions (Figure 3E). After
0–120 min of incubation, an aliquot of the reaction was re-
moved, and GDH activity was measured by monitoring
NADH absorbance. SIRT4, but not the buffer control, re-
duced the enzymatic activity of GDH by at least 50%
(Figure 3E and Figure S1D). Moreover, SIRT4 was not
inhibitory when NAD was omitted (Figure S1D) or in the
presence of nicotinamide (Figure 3E), suggesting that
ADP-ribosylation by SIRT4 is required for GDH inhibition.
In contrast, SIRT1-FLAG had little effect on GDH activity
(Figure 3E).
Generation and Characterization
of SIRT4 Knockout Mice
To test whether SIRT4 regulates GDH activity in vivo, we
generated SIRT4 knockout (KO) mice by replacing exons
1–3 of the SIRT4 gene with a LacZ gene (Figure 4A). The
lack of SIRT4 protein was verified by Southern blot analy-
sis of genomic DNA (Figure 4B) and by Western blot
with NAD glycohydrolase (NADase) (lane 2), GDH (lane 3), hSirT4
(lane 4), hSIRT4 and GDH (lane 5), and Sir2Tm and the acetylated
p53 peptide JB12 (lane 6). The reactions were incubated for 1 hr and
analyzed by TLC and autoradiography. The arrows indicate the posi-
tions where NAD+ and ADP-ribose migrate.
(E) The enzymatic activity of GDH (50 mg in 200 ml) was measured after
a 0, 15, 60, and 120 min incubation at 37C. Reactions contained 1 mM
NAD and 10 ng hSIRT-FLAG without (-) or with (,) 10 mM nicotin-
amide, 20 ng hSIRT1-FLAG (A), or mock IP buffer (B). The sirtuins
were monitored by blotting with anti-FLAG and GDH by Ponceau S
staining. Experiments were repeated in triplicate. In this and all other
figures, values are expressed as mean + standard error of the mean
(SEM).Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc. 945
Figure 4. SIRT4 Mediates GDH ADP-Ribosylation In Vivo
(A) A LacZ cassette was inserted into the mouse SIRT4 gene in-frame with the first part of exon 1, deleting exons 1–3.
(B) Genotypes were determined by Southern blotting of BamHI-digested genomic DNA with the probe indicated by the black bar in (A).
(C) Lysates from wild-type and SIRT4 KO brain (B), pancreas (P), and liver (L) were blotted with the indicated antibodies.
(D) GDH activity was measured in pancreatic mitochondrial lysates (20 mg) from SIRT4 wild-type (open bar) or KO mice (black bar) (n = 4). GDH protein
levels were measured in three of these samples by immunoblotting for GDH and HSP60.
(E) GDH activity was measured from 100 wild-type (open bar) or KO (black bar) islets lysed in NP-40 buffer with or without PDE treatment (10 mg/ml) for
15–20 min at 37C.
(F) Left: Liver mitochondrial lysates were immunoprecipitated with resin conjugated with preimmune serum, anti-mono-ADP-ribose, or anti-GDH in
the absence or presence of PDE for 4 hr at 4C. Immunoprecipitates were run out adjacent to antibody-conjugated resin that had not been incubated
with lysate and were then blotted with GDH antibodies conjugated to horseradish peroxidase. The blot was reprobed with anti-rabbit secondary an-
tibodies; the heavy chain is shown as a loading control. Right: Nine separate experiments of the anti-ADP-ribose immunoprecipitation were quanti-
tated by ImageJ (NIH), as shown.946 Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc.
analysis of brain, pancreas, and liver lysates (Figure 4C).
SIRT4 KO mice were viable, fertile, and did not display
gross phenotypic abnormalities when compared with
wild-type littermates. All subsequent measurements
were performed on isogenic 129 strain littermates of
wild-type and KO mice.
Pancreatic mitochondrial lysates from KO mice ex-
hibited higher GDH activity than wild-type controls without
an increase in GDH protein levels (Figure 4D; p < 0.01). As
b cells comprise less than 1% of total pancreas, we next
measured GDH activity from isolated pancreatic islets
and found that activity was significantly higher in SIRT4
KO mice compared with littermate controls (Figure 4E).
To understand why GDH activity was higher in SIRT4 KO
mice, we investigated whether GDH activity in islet lysates
was increased by PDE treatment. PDE can serve as a
probe for whether ADP-ribosylation downregulates
enzymes because it cleaves the ADP-ribose moiety and
can thereby relieve inhibition (Witters and McDermott,
1986). Incubation with PDE increased the activity of
wild-type lysates to the level of KO samples (Figure 4E).
By contrast, SIRT4 KO lysates were not affected by PDE
treatment (Figure 4E). These results strongly suggest
that GDH activity is inhibited by SIRT4-mediated ADP-
ribosylation in vivo.
We further examined the ADP-ribosylation status of
GDH in wild-type and KO mitochondrial lysates by a phys-
ical assay. Mono-ADP-ribose antibodies pulled down
more GDH from wild-type liver lysates than from KO
(Figure 4F). This difference was minimized when lysates
were preincubated with PDE. Data from nine such exper-
iments were compiled and are represented in the bar
graph in Figure 4F. Taken together, the above data sug-
gest that SIRT4 represses GDH activity by ADP-ribosylat-
ing it in vivo.
We tested whether SIRT4 affects mitochondrial ADP-ri-
bosylation by another assay, in which we incubated com-
parable amounts of wild-type and KO liver mitochondrial
lysates (Figure 4G, lanes 1–4) with [32P]NAD. We observed
higher ADP-ribosylation in wild-type mitochondria com-
pared with KO samples in the longer, 1.5 hr time point
(Figure 4G, lanes 7 and 8), indicating that KO mitochondria
have decreased ADP-ribosyltransferase activity. Specifi-
cally, we observed a significant difference in the ADP-
ribosylation of a 56 kDa band, which was previously
determined to be GDH (Herrero-Yraola et al., 2001), a con-
clusion we verified by immunoprecipitation (data not
shown). The labeling observed in the short time point
(10 min, lanes 5 and 6) or long time point of the KO sample
(lane 8) could represent a background due to nonenzy-
matic labeling. Alternatively, there may be another
mitochondrial ADP-ribosyltransferase or nonmitochon-
drial contaminant in our preparations.SIRT4 Represses Insulin Secretion in Response
to Glucose and Amino Acids
We next investigated a biological role for the regulation of
GDH by SIRT4. Insulin release from pancreatic b cells can
be induced by amino acids, a process termed amino acid-
stimulated insulin secretion (AASIS) (Cline et al., 2004;
Kelly and Stanley, 2001; Sener and Malaisse, 1980). For
example, leucine is a potent insulin secretagogue be-
cause its conversion into TCA-cycle intermediates pro-
vides energy (for review, see MacDonald et al., 2005). In
addition, leucine directly stimulates GDH, thereby allow-
ing glutamate to fuel the TCA cycle and induce insulin se-
cretion (Sener and Malaisse, 1980). Glucose represses
AASIS, in part, by triggering a surge in GTP, which binds
to and inhibits GDH (Li et al., 2003). Indeed, humans
with mutations in GDH that render it insensitive to inhibi-
tion by GTP display hyperinsulinism/hyperammonemia
(HI/HA) syndrome (Stanley et al., 1998).
To test whether SIRT4 regulates insulin secretion by re-
pressing GDH, we first examined how this sirtuin affects
insulin secretion in MIN6 cells. Using two separate RNAi
sequences, we constructed stable MIN6 pools with de-
creased levels of SIRT4 compared to control cells
(Figure 5A). SIRT4 RNAi cells secreted more insulin com-
pared to control cells at noninducing and inducing con-
centrations of glucose (Figure 5B; p < 0.05) and also dis-
played increased levels of ATP and rates of oxygen
consumption (Figures S1E and S1F). SIRT4 RNAi cells
had growth rates similar to control cells (Figure 5C).
To investigate whether knockdown ofSIRT4 potentiates
AASIS, cells were challenged with glutamine, which is con-
verted to glutamate in cells. Glutamine must normally be
added with leucine to induce insulin, as discussed above
(Li et al., 2003; Sener and Malaisse, 1980). Strikingly, in
the SIRT4 RNAi cells, glutamine alone stimulated insulin
secretion, while control MIN6 cells were unresponsive
(Figure 5D; p < 0.01). SIRT4 RNAi also increased GDH ac-
tivity (Figure S1G). We tested whether GDH is required for
the increases in glucose and amino acid insulin secretion
and AASIS in SIRT4 knockdown cells by constructing sta-
ble MIN6 lines expressing RNAi for both SIRT4 and GDH
(Figure 5A). Double-knockdown cells displayed reduced
levels of both SIRT4 and GDH. Moreover, these cells did
not secrete more insulin in response to glucose and did
not respond to glutamine (Figure 5D), indicating that the
high insulin secretion in response to glucose and the AASIS
seen in the SIRT4 deficiency were GDH dependent.
We next determined whether insulin secretion was reg-
ulated by SIRT4 in vivo by studying SIRT4 KO mice. In the
absence of SIRT4, mice had a 30% increase in circulating
insulin levels during ad libitum feeding (Figure 6A; p <
0.001). When subjected to an overnight fast, KO animals
had significantly higher insulin levels compared with(G) Mitochondria from wild-type and KO livers were incubated with [32P]NAD for 10 or 90 min, run on SDS-PAGE, and transferred to
nitrocellulose. Proteins were visualized by Ponceau S staining (lanes 1–4), and ADP-ribosylation was monitored by autoradiography (lanes
5–8).Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc. 947
Figure 5. SIRT4 Regulates Insulin Secretion in MIN6 Insulinoma Cells via GDH
(A) Immunoblot showing that levels of SIRT4, GDH, or both (SIRT4/GDH) were decreased by RNAi compared to control MIN6 cells. Cells were stably
infected with viruses that contained two SIRT4 (SIRT4-a and SIRT4-b) RNAi sequences, GDH RNAi, both SIRT4/GDH RNAi, or pSUPER-retro (con-
trol). SIRT4a and SIRT4b lines gave similar results for secretion assays; only SIRT4a is shown in further experiments.
(B) Insulin secretion was measured from control or the indicated RNAi cells in buffer containing 3 mM (open bars) or 16.7 mM glucose (filled bars).
(C) Representative growth curves from control (-) and SIRT4 RNAi (,) cells.
(D) Insulin secretion was measured in control cells (open bars) or cells expressing RNAi for SIRT4 (black bars), GDH (light gray bars), or both SIRT4/
GDH (dark gray bars) incubated in buffer containing 0.1, 1, or 10 mmol/l glutamine for 2 hr at 37C. Assays in (B) and (D) were performed at least three
times using cell lines from two to four separate transfections.wild-type littermates (Figure 6A; p < 0.001). Fed glucose
levels were similar between wild-type and KO mice, while
male KO mice showed slight but significant fasting hypo-
glycemia compared to littermate controls (Figure 6B; p <
0.01). Females did not show a statistical difference in glu-
cose levels (data not shown). The increase in insulin levels
in KO mice was not due to glucose intolerance; if anything,
the KO mice were slightly more tolerant (Figure 6C). We
next measured whether an IP injection of glutamine stim-
ulated insulin secretion in fasted KO mice. Strikingly, glu-
tamine increased plasma insulin substantially in KO mice
(Figure 6D). In contrast, wild-type animals did not respond
to glutamine (Figure 6D).
To test whether b cells from the SIRT4 KO mice display
elevated insulin secretion, we isolated islets and mea-
sured insulin secretion in response to glucose. We found
significantly higher insulin secretion from KO islets under
glucose-induced conditions (Figure 6E). Moreover, KO is-
lets showed a dosage-dependent increase in glutamine-
stimulated insulin secretion, while wild-type islets were
unresponsive (Figure 6F). KO islets also showed higher
leucine-stimulated insulin secretion (Figure 6F) but resem-
bled wild-type islets with respect to total insulin content
and morphology (Figure 6G). These data show that
SIRT4 functions as a negative regulator of insulin secretion
and AASIS in mouse b cells in vivo and ex vivo.948 Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc.CR Regulates GDH Activity and AASIS
Sir2 is involved in physiological changes during CR in
yeast and Drosophila. More recently, SIRT1 has been
shown to be required for at least one phenotype induced
by CR in mice, the increase in physical activity (Chen
et al., 2005). We hypothesized that SIRT4 may also
play a role in physiological changes during CR in mam-
mals. A substantial body of data suggests that protein
turnover is increased by CR and that amino acids are
used as carbon and energy sources to drive gluconeo-
genesis in the liver (Dhahbi et al., 2001; Hagopian et al.,
2003a, 2005). Thus, it seemed reasonable that b cells
of CR mice might respond to amino acids as insulin
secretagogues.
To address whether CR potentiates AASIS, we first
measured changes in SIRT4 and GDH protein levels in
pancreatic islets from CR mice. While GDH protein levels
were unaffected by CR, there was significantly higher
GDH activity in CR islet lysates compared with non-CR
control lysates (Figures 7A and 7B). Moreover, treatment
of the non-CR islet lysates with PDE increased GDH activ-
ity to the level of the CR lysates but did not further increase
GDH activity in the CR lysates (Figure 7B), suggesting that
GDH is ADP-ribosylated and downregulated in islets un-
der non-CR conditions, but not during CR. The effects of
CR on GDH activity parallel what we observed in SIRT4
Figure 6. SIRT4 Regulates Insulin Secretion In Vivo
(A) Plasma insulin was measured in SIRT4 wild-type (open bars throughout figure) or SIRT4 KO (black bars throughout figure) mice fed ad libitum or
after an overnight (14 hr) fast. (n = 15–25).
(B) Blood glucose was measured in SIRT4 wild-type or SIRT4 KO mice fed ad libitum or after an overnight (14 hr) fast (n = 15–25).
(C) Blood glucose was measured after an IP injection in fasted animals (1 g/kg body weight from a 10% glucose [w/v] solution) (n = 6).
(D) Glutamine-stimulated insulin secretion in SIRT4 wild-type or SIRT4 KO mice. Glutamine (0.2 g/kg body weight of a 2% solution) was injected IP in
fasted mice, and insulin was measured at 0 min (before injection) and 10 min after injection (n = 6).
(E and F) Insulin secretion was measured in isolated islets (eight islets per concentration in duplicate) from SIRT4 wild-type or SIRT4 KO mice stim-
ulated with 3 mM or 17 mM glucose (E) or 0.1, 1, or 10 mM glutamine or 20 mM leucine (F).
(G) Insulin content of pancreatic islets was measured in batches of eight islets (n = 15 batches in three separate experiments). Representative islets
from SIRT4 wild-type or SIRT4 KO mice are shown. *p < 0.01, **p < 0.001 by Wilcoxon rank-sum test.KO pancreas, thereby suggesting that SIRT4 activity is
downregulated by CR.
To test directly whether CR potentiates AASIS, we iso-
lated islets from control and CR pancreas for ex vivo anal-
ysis. We found that glucose-stimulated insulin secretion
was not affected by CR compared with control islets
(Figure 7C). However, there was a striking increase in glu-
tamine- and leucine-stimulated insulin secretion in iso-
lated CR islets compared to controls (Figures 7D and
7E). These results demonstrate a switch to AASIS during
CR, similar to what was observed in SIRT4 KO mice, fur-ther suggesting that SIRT4 activity is downregulated by
CR to mediate this switch.
Because GDH activity has been reported to be
upregulated in liver during CR (Hagopian et al.,
2003a), we tested whether changes in ADP-ribosylation
were also responsible for this regulation. As in islets, CR
did not affect the levels of GDH in liver lysates
(Figure 7F) but gave rise to higher GDH activity com-
pared to controls (Figure 7G). Also, repeated analyses
of SIRT4 did not reveal significant differences in protein
levels in control versus CR. Moreover, the GDH activityCell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc. 949
Figure 7. Calorie Restriction Potentiates AASIS
(A) Lysates from two sets of islets from control (C) or calorie-restricted (CR) mice were analyzed by SDS-PAGE and Western blotting using antibodies
to SIRT4, GDH, and tubulin.
(B) GDH activity was measured in 100 control (open bars) or CR (gray bars) islets without or with PDE treatment, as described for Figure 4E.
(C–E) Insulin secretion was measured in isolated islets (duplicate assays using five islets for each measurement) from control (open bars) or CR (gray
bars) mice stimulated with glucose (C), glutamine (D), or leucine (E). Islets from six control and six CR mice were used.
(F) Liver lysates from five control and five CR mice were analyzed by Western blotting using antibodies to SIRT4, GDH, and tubulin.
(G) GDH activity was measured in liver lysates from five control (open bars) and five CR (gray bars) mice without or with PDE treatment, as described
for Figure 4E.in control lysates was increased by PDE treatment to
levels observed in CR livers. PDE did not affect GDH
activity in the CR liver lysates. These findings suggest
that, as in islets, GDH is ADP-ribosylated and downre-950 Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Incgulated in the liver under non-CR conditions, but not
during CR.
To address whether GDH activity is altered in tissues
other than pancreas and liver during CR, we also.
measured GDH activity and sensitivity to PDE in control
and CR brain (cerebellum) lysates. SIRT4 and GDH protein
levels were not significantly altered by CR (Figure S2A).
However, as in pancreas and liver, we found that GDH ac-
tivity was increased in CR compared with control lysates
(Figure S2B). Again, the lower level of activity in control ly-
sates was stimulated by PDE, but the higher activity in CR
lysates was not, indicating that regulation occurred by
ADP-ribosylation of GDH.
DISCUSSION
We show that the mammalian SIR2 homolog SIRT4 regu-
lates insulin secretion in pancreatic b cells. Several lines of
evidence support a model in which SIRT4 regulates AASIS
in b cells in response to diet by ADP-ribosylating and re-
pressing mitochondrial GDH. First, SIRT4 and GDH are
expressed (Figure 1B and Figure 2D) and interact in mito-
chondria of b cells (Figure 2F). Second, both immunopre-
cipitated and recombinant SIRT4 ADP-ribosylate GDH
in vitro (Figure 3). Third, SIRT4 inhibits GDH activity in vitro
(Figure 3E). Fourth, GDH is activated in wild-type lysates
by PDE, indicating that it is normally repressed by ADP-
ribosylation (Figure 4E). Fifth, GDH activity is higher in
SIRT4 KO mice and can not be further activated by PDE
treatment (Figures 4D and 4E). Sixth, SIRT4 KO mice dis-
play increased insulin secretion in response to glutamine
and leucine (Figure 6F). These KO mice do not show
a change in levels of GDH (Figure 4D) or other markers
of mitochondrial function (Figure S2C). Seventh, GDH ac-
tivity is elevated during CR and is not further stimulated by
PDE (Figure 7B). Eighth, CR islets secrete more insulin in
response to glutamine and leucine compared to controls
(Figures 7D and 7E).
We conclude that SIRT4 ADP-ribosylates and downre-
gulates GDH in b cells during calorie-sufficient conditions,
thereby preventing glutamine from serving as an insulin
secretagogue. However, during CR, there is an increase
in GDH activity, which upregulates insulin secretion in re-
sponse to glutamine and leucine. Unlike GDH from control
mice, GDH from CR mice is insensitive to PDE treatment,
suggesting that it is less ADP-ribosylated. We thus sur-
mise that the SIRT4 ADP-ribosyltransferase is downregu-
lated by CR, a change that goes against the expectation
that sirtuin functions increase during CR. However, it is
consistent with the following molecular and physiological
considerations. First, we did not observe an induction in
SIRT4 protein levels in b cells of CR mice (Figure 7A). Sec-
ond, it has been reported that fatty-acid oxidation in mito-
chondria is upregulated by CR to provide energy (Tsu-
chiya et al., 2004), which should result in a substantial
conversion of NAD to NADH in that cellular compartment.
Indeed, a reduction in the NAD/NADH ratio has been re-
ported in liver mitochondria during CR (Hagopian et al.,
2003b) and in pancreas during overnight starvation (Bor-
done et al., 2005). A change in the NAD/NADH ratio regu-
lates yeast Sir2p during CR (Lin et al., 2004). A lower NAD/NADH ratio during CR may therefore downregulate SIRT4
activity and thus reduce ADP-ribosylation of GDH.
Coordination between b Cells and Liver during CR
Because amino acids serve as carbon and energy sources
during CR (Dhahbi et al., 2001; Hagopian et al., 2003a;
Tsuchiya et al., 2004), they have the potential to fuel glu-
cose synthesis in the liver. Our finding that CR induces
AASIS in b cells (Figures 7D and 7E) fits the idea that
this regimen shifts the burden of energy provision from
carbohydrates toward proteins derived from the diet. A
previous study found elevated liver GDH activity during
CR (Hagopian et al., 2003a), and our data suggest that
this regulation occurs by a reduction in ADP-ribosylation
of the liver enzyme (Figure 7G). By this logic, ADP-ribosy-
lation of GDH may coordinate amino acid metabolism in
different tissues with changes in diet—i.e., during CR, a re-
duction in ADP-ribosylation upregulates GDH in the liver to
potentiate gluconeogenesis and in b cells to potentiate
AASIS. In contrast to the altered response of CR islets to
amino acids, their response to glucose was unchanged
from calorie-sufficient mice (Figure 7C), consistent with
previous findings (Reaven et al., 1983).
Opposing Roles of SIRT4 and SIRT1
in Insulin Secretion
SIRT1 functions as a positive regulator of glucose-stimu-
lated insulin secretion (GSIS) in b cells (Moynihan et al.,
2005) by repressing the mitochondrial uncoupling protein
UCP-2 (Bordone et al., 2005). In contrast, SIRT4 appears
to downregulate GSIS and AASIS. It is not certain whether
the observed effect of SIRT4 on GSIS, like its effect on
AASIS, is due to downregulation of GDH. While the in vitro
study in MIN6 insulinoma cells suggests that the increase
in GSIS in SIRT4 knockdown cells requires GDH, more
experiments will be required to resolve the question of
whether SIRT4 affects other mitochondrial proteins that
can influence GSIS.
It is striking that at least two of the seven sirtuins appear
to regulate insulin secretion, apparently in opposing direc-
tions. It is possible that regulation by these sirtuins is in-
voked under subtly different dietary conditions. SIRT1-
mediated repression of UCP-2 is alleviated by acute
food deprivation (Bordone et al., 2005), indicating that
this mechanism may function to dampen insulin secretion
during starvation. In contrast, SIRT4 repression of GDH
was alleviated during long-term CR, resulting in activation
of AASIS in b cells and potentially gluconeogenesis in liver.
Thus, SIRT1 and SIRT4 may serve to regulate insulin se-
cretion under conditions that span the range of food avail-
ability, from acute starvation to chronic food limitation.
Mitochondrial Sirtuins
SIRT4 is a mitochondrial ADP-ribosyltransferase that
modifies GDH to affect insulin secretion and amino acid
metabolism in pancreas, liver, and brain. It will be interest-
ing to determine whether SIRT4 regulates additional path-
ways by ADP-ribosylating other mitochondrial proteins.Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Inc. 951
Indeed, our study of ADP-ribosylation of mitochondrial
proteins in vitro (Figure 4G) indicated other potential tar-
gets of SIRT4. The other mitochondrial sirtuin that has
been studied in detail is SIRT3. Unlike SIRT4, SIRT3 dis-
plays NAD-dependent deacetylase activity (Onyango
et al., 2002; Schwer et al., 2002). SIRT3 has been reported
to be upregulated by CR and cold exposure in brown fat,
where it may alter the metabolic activity of this tissue (Shi
et al., 2005). Because the enzymatic activity of both sir-
tuins is influenced by mitochondrial NAD/NADH ratios
and the level of nicotinamide, it will be interesting to learn
how coordination of acetylation and ADP-ribosylation by
these sirtuins regulates mitochondria.
Summary and Perspective
SIRT4 regulates insulin secretion in b cells by ADP-ribosy-
lating and downregulating GDH in mitochondria. ADP-
ribosylation of GDH, as judged by sensitivity to PDE, is
reduced by long-term CR in islets and liver, suggesting
that CR downregulates SIRT4 activity, perhaps by lower-
ing the NAD/NADH ratio. The increase in GDH activity
during CR potentiates amino acids as insulin secreta-
gogues. It will be important to determine whether other
mammalian sirtuins also help coordinate the multiple
effects of CR on health and life span.
EXPERIMENTAL PROCEDURES
Animal Experimentation
Littermate 129/Sv (8–12 weeks old) mice were used for the present
studies. The SIRT4 KO targeting vector was constructed by replacing
exons 1–3 with a LacZ gene inserted in-frame after the first 21 bp of
exon 1 using the recombineering method (Valenzuela et al., 2003).
Mice were housed under controlled temperature (25C) and light, fed
normal chow, and euthanized by CO2. Organs were harvested and ho-
mogenized and mitochondria from cells and tissues were isolated as
described (Schwer et al., 2002). For CR studies, C57BL/6 mice were
subjected to CR for 12 months as described (Pugh et al., 1999).
Insulin Assays
Plasma insulin levels were determined by ELISA (Alpco Diagnostics,
Windham, NH, USA). Glucose levels were measured using a one-
step glucometer. For islet insulin secretion assays, pancreata were di-
gested by incubation with collagenase (0.4 mg/ml) in HBSS, 1 MgCl2,
and 3 mM glucose at 37C while shaking. Islets were separated from
tissue by a series of centrifugation and wash steps. Handpicked
groups of 5–8 islets were cultured for 2 hr or overnight in RPMI media
(10 mM glucose, 10% FBS). To stimulate insulin secretion, islets (or
MIN6 cells, passage 29–40) were incubated in Krebs-Ringer-HEPES
buffer (KRB; pH 7.4 128 mM NaCl, 5 mM KCl, 2.7 mM CaCl2, 1.2
mM MgSO4, 1 mM Na2HPO4, 20 mM HEPES) containing 3 mM glucose
for 1 hr. Then, islets were incubated in KRB containing glucose, gluta-
mine, or leucine at 37C for 1–2 hr. Supernatants containing insulin
were stored at 20C until analysis. Total islet insulin was measured
in islets treated with ethanol overnight at 20C. Retroviral infection
was performed as described (Picard et al., 2004) using MIN6 cells.
Four independent stable lines were created for each RNAi, and exper-
iments were repeated two or three times in each line.
Immunoprecipitation/Microscopy
For immunoprecipitation, cells were lysed for 30 min at 4C in ice-cold
NP40 buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 1% NP40) containing
protease inhibitors (EDTA-free Complete; Roche Molecular Biochem-952 Cell 126, 941–954, September 8, 2006 ª2006 Elsevier Incicals, Indianapolis, IN, USA) and 1 mM DTT (Sigma, St. Louis). The ly-
sate was clarified by centrifugation for 15 min at 4C at 14,000 rpm in
a tabletop centrifuge, immunoprecipitated at 4C for 2 hr, washed, and
immunoblotted; signal was detected using ECL (Amersham Biosci-
ences, Piscataway, NJ, USA). One percent to five percent of the lysate
was used as the input control.
HepG2 cells were grown on coverslips and transfected with
phSIRT4GFP, pDsRed2-Mito, or pDsRed2-Peroxi (BD Biosciences,
Palo Alto, CA, USA). After 48 hr, cells were fixed with paraformalde-
hyde and analyzed using a confocal microscope (Zeiss LSM 510;
Zeiss, Thornwood, NY, USA).
Immunohistochemistry in mouse pancreas was performed using
a microwave citrate unmasking protocol. An antibody for mouse
SIRT4 was created in rabbit against the peptide LEMNFPLSSAAQDP.
Antibodies to insulin and GDH were from Zymed Laboratories (San
Francisco) and USBiological, respectively. Antibodies to FLAG and
Gal4 were from Sigma. Mono-ADP-ribose antibody was a generous
gift from H. Hilz (Meyer and Hilz, 1986). Secondary antibodies were ob-
tained from Molecular Probes (Eugene, OR, USA).
Recombinant SIRT4
The EasySelect Pichia expression kit (Invitrogen, Carlsbad, CA, USA)
was used to prepare recombinant P. pastoris clones expressing
hSIRT4 (residues 25–314) for intracellular expression. Recombinant
hSIRT4 was dialyzed in 50 mM Tris (pH 8.0), 10 mM 2-mercaptoetha-
nol, 100 mM NaCl; protein was applied to a MonoQ anion exchange
column (Amersham Biosciences); and hSIRT4 was eluted with a 0.1–
1 M NaCl gradient.
Enzyme Assays
FLAG-tagged SIRT1, SIRT4, and SIRT5 proteins were purified by im-
munoprecipitation and eluted in FLAG buffer (50 mM Tris [pH 8.0],
150 mM NaCl, 1 mM DTT, 0.1 mg/ml FLAG peptide). Deacetylase ac-
tivity of dialyzed protein (50 ng) was assessed with or without 1 mM
NAD by the Fluor de Lys kit (BIOMOL Research Laboratories, Inc., Ply-
mouth Meeting, PA, USA). ADP-ribosylation activity was assessed as
described (Tanny et al., 1999) using FLAG proteins (50 ng) and core
histone (1 mg) in the presence of 1 mM NAD and with or without 1
mM nicotinamide in 50 mM Tris buffer (pH 8.0), 10 mM DTT, 150 mM
NaCl. For recombinant hSIRT4, assays were performed by incubating
5 mCi [32P]NAD with GDH (10 mg) at 37C for 1 hr with or without hSIRT4
(1 mg), hSIRT4 alone, 2 mg Neurospora crassa NAD glycohydrolase
(Sigma), TmSIR2 (2 mg), or 1 mM acetylated peptide JB12 (Sauve
et al., 2001).
GDH activity was assessed as described (Herrero-Yraola et al.,
2001). Briefly, GDH (10 mg, Sigma) activity was measured after incuba-
tion in the presence or absence of SIRT4 (10 ng) or 1 mM NAD+ at 37C
for the indicated times.
Thin-layer chromatography was used to analyze NAD metabolites
produced by sirtuin activity. Two microliters from each reaction was
spotted on PEI-cellulose TLC plates (Macherey-Nagel, Easton, PA,
USA) and developed with 300 mM LiCl. After drying the TLC plate, it
was exposed to film for 15 min.
Mitochondrial labeling experiments were performed as described
(Jorcke et al., 1998). In brief, wild-type or KO liver mitochondria were
incubated with 1 mM NAD (containing 20 mCi [32P]NAD) for 10 or 90
min at 37C. Labeled proteins were visualized by autoradiography.
Statistical Analysis
Analysis was performed using an unpaired Student’s t test, and signif-
icant differences are indicated by an asterisk when p < 0.05.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and two figures and can be found with this article online at http://
www.cell.com/cgi/content/full/126/5/941/DC1/..
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